Publication
Good correlation between plasma cytokeratin-18 and controlled attenuation parameter (CAP) in healthy population
| dc.contributor.author | Carvalhana, Sofia | |
| dc.contributor.author | Leitão, Jorge | |
| dc.contributor.author | Alves, Catarina | |
| dc.contributor.author | Bourbon, Mafalda | |
| dc.contributor.author | Cortez-Pinto, Helena | |
| dc.date.accessioned | 2015-02-17T15:09:47Z | |
| dc.date.available | 2015-02-17T15:09:47Z | |
| dc.date.issued | 2014-10 | |
| dc.description.abstract | Introduction: Liver steatosis measurement by controlled attenuation parameter (CAP) is a noninvasive method for diagnosing steatosis1. Plasma caspase-generated cytokeratin-18 fragments (CK-18) have been proposed as a non-invasive alternative for the diagnosis of NAFLD, especially NASH2. Aims: compare CK-18 serum levels in apparently healthy individuals with and without steatosis. | por |
| dc.identifier.uri | http://hdl.handle.net/10400.18/2874 | |
| dc.language.iso | eng | por |
| dc.subject | Determinantes Imunológicos em Doenças Crónicas | por |
| dc.subject | Hepatic Steatosis | |
| dc.title | Good correlation between plasma cytokeratin-18 and controlled attenuation parameter (CAP) in healthy population | por |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Vienna, Austria | por |
| oaire.citation.title | 22nd United European Gastroenterology Annual Meeting (UEG Week), October 18-22, 2014 | por |
| rcaap.rights | restrictedAccess | por |
| rcaap.type | conferenceObject | por |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Good correlation between plasma cytokeratin-18.pdf
- Size:
- 297.96 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: